Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
150 GBX | 0.00% | +7.14% | -50.82% |
May. 03 | Kelso raises stake in NCC; Transense joins project | AN |
Apr. 30 | Faron Pharmaceuticals Ltd. Announces Appointment of Dr. Juho Jalkanen as Director | CI |
Evolution of the average Target Price on Faron Pharmaceuticals Oy
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
EPS Revisions
- Stock Market
- Equities
- FARN Stock
- Consensus Faron Pharmaceuticals Oy